BIARYL SUBSTITUTED HETEROCYCLE INHIBITORS OF LTA4H FOR TREATING INFLAMMATION
申请人:Sandanayaka Vincent
公开号:US20070066820A1
公开(公告)日:2007-03-22
The present invention relates to a chemical genus of biaryl substituted heterocycle inhibitors of LTA4H (leukotriene A4 hydrolase) useful for the treatment and prevention and prophylaxis of inflammatory diseases and disorders. The compounds have general formula Ψ:
An example is
[EN] PROCESS FOR PREPARING 4- { (S) -2- (4-(4-CHLOROPHENOXY) PHENOXYMETHYL) PYRROLIDIN-1-YL) } BUTYRIC ACID AND SALTS THEREOF<br/>[FR] PROCÉDÉ DE PRÉPARATION DE L'ACIDE 4-{(S)-2-(4-(4-CHLOROPHÉNOXY)PHÉNOXYMÉTHYL)PYRROLIDIN-1-YL}BUTYRIQUE ET DE SES SELS
申请人:DECODE GENETICS EHF
公开号:WO2011011598A1
公开(公告)日:2011-01-27
The present invention relates to a process for preparing 4-(S)-2-[4-(4-chlorophenoxy)phenoxymethyl]pyrrolidin-1-yl}butyric acid and its salts.
Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammation
申请人:deCODE genectics ehf.
公开号:US07402684B2
公开(公告)日:2008-07-22
The present invention relates to a chemical genus of biaryl substituted heterocycle inhibitors of LTA4H (leukotriene A4 hydrolase) useful for the treatment and prevention and prophylaxis of inflammatory diseases and disorders. The compounds have general formula Ψ:
An example is